Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024)

Oculis Holding AG (OCS) posted quarterly Cash from Investing Activities of -$19.7 million for Q2 2024, down 738.58% quarter-over-quarter from -$2.3 million in Q1 2024.

Analysis

Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024) Analysis & Trends

Oculis Holding AG's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$19.7 million for Q2 2024.

  • In Q2 2024, Cash from Investing Activities changed N/A year-over-year to -$19.7 million; the TTM figure through Jun 2024 stood at -$464875.5 (changed N/A YoY), while the FY2025 annual figure was -$73.5 million, down 302.01% from the prior year.
  • Cash from Investing Activities for Q2 2024 stood at -$19.7 million, down from -$2.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $25.9 million in Q4 2023, with the low at -$19.7 million in Q2 2024.
  • The 3-year median for Cash from Investing Activities is -$2.0 million (2024), against an average of -$427938.7.
  • Peak annual rise in Cash from Investing Activities reached 1744.57% in 2023, while the deepest fall reached 714.06% in 2023.
  • Oculis Holding AG's Cash from Investing Activities stood at -$1.6 million in 2022, then soared by 1744.57% to $25.9 million in 2023, then slumped by 176.04% to -$19.7 million in 2024.
  • Business Quant data shows OCS's Cash from Investing Activities at -$19.7 million in Q2 2024, -$2.3 million in Q1 2024, and $25.9 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -19.67 Mn
Mar 31, 2024 -2.35 Mn
Dec 31, 2023 25.86 Mn
Sep 30, 2023 -4.32 Mn
Dec 31, 2022 -1.57 Mn
Sep 30, 2022 -530,153.80